SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.

Saved in:
Bibliographic Details
Title: SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.
Authors: Barosi G; Laboratory of Clinical Epidemiology and Center for the Study of Myelofibrosis, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. barosig@smatteo.pv.it, Merlini G, Billio A, Boccadoro M, Corradini P, Marchetti M, Massaia M, Tosi P, Palumbo A, Cavo M, Tura S
Source: Annals of hematology [Ann Hematol] 2012 Jun; Vol. 91 (6), pp. 875-88. Date of Electronic Publication: 2012 Apr 04.
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0584
DOI:10.1007/s00277-012-1445-y